Related Experiment Video
Updated: Mar 10, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Global epidemiology and burden of HCV infection and HCV-related disease
Aaron P Thrift1,2, Hashem B El-Serag1,3, Fasiha Kanwal1,3
1Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, 7200 Cambridge Street, Suite 10C, Houston, Texas, USA.
Insights
Chronic Hepatitis C Virus (HCV) infection impacts over 184 million globally, causing liver and other diseases. Understanding HCV
Area of Science:
- Hepatology
- Infectious Diseases
- Epidemiology
Background:
- Chronic Hepatitis C Virus (HCV) infection is a significant global health issue affecting over 184 million individuals.
- HCV is linked to numerous hepatic and extrahepatic disorders, including various malignancies.
- The disease burden is shaped by incidence, prevalence, and the infection's natural history.
Purpose of the Study:
- To review the global epidemiology and burden of HCV infection and its complications.
- To discuss the natural history and clinical course of both chronic and cured HCV infection.
- To inform strategies for detection, prognostication, and treatment in light of new antiviral therapies.
Main Methods:
- This is a review article.
- It synthesizes existing data on HCV epidemiology and natural history.
- Focuses on factors influencing HCV burden and disease progression.
Main Results:
- HCV infection presents a substantial global health burden with significant variations across populations and regions.
- Demographic, virological, clinical, and lifestyle factors influence the natural history of HCV.
- New antiviral treatments necessitate understanding disease burden changes in both chronic and cured patients.
Conclusions:
- Effective HCV management requires understanding the determinants of its global burden.
- Further research is needed on the long-term outcomes and disease burden in patients cured of HCV.
- This review provides a comprehensive overview to guide future public health interventions and clinical management.
Abstract:
Chronic HCV infection is a global health problem that affects >184 million people worldwide. HCV is associated with several hepatic and extrahepatic disorders, including several malignancies. The burden of HCV-related disorders is influenced by the number of new and existing cases, number of existing cases and the natural history of the infection. The natural history of HCV is affected by several demographic, virological, clinical and lifestyle factors. Major variations exist in the burden of HCV among different populations and geographical regions, as well as over time. With the advent of new and efficacious antiviral treatments, it is important to learn the determinants of HCV burden to design appropriate strategies for detection, prognostication and treatment. Furthermore, with the expected growth of patients cured of HCV, it is essential to learn about the possible change in natural history and burden of disease in these patients. In this Review, we will discuss the global epidemiology and burden of HCV and its complications, as well as the natural history and clinical course of chronic and cured HCV infection.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Causality in Epidemiology
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Introduction to Epidemiology
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

